CCM

Cutter Capital Management Portfolio holdings

AUM $230M
1-Year Est. Return 11.51%
This Quarter Est. Return
1 Year Est. Return
+11.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$244M
AUM Growth
-$94.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$20.5M
2
+$18.1M
3
+$12.9M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$12.1M
5
AMGN icon
Amgen
AMGN
+$9.93M

Top Sells

1
+$30.1M
2
+$29.7M
3
+$17.9M
4
LEGN icon
Legend Biotech
LEGN
+$15.9M
5
LLY icon
Eli Lilly
LLY
+$15.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNA icon
26
Avidity Biosciences
RNA
$7.15B
– –
-160,947
ELVN icon
27
Enliven Therapeutics
ELVN
$1.31B
– –
-207,896
GILD icon
28
Gilead Sciences
GILD
$153B
– –
-359,025
HRMY icon
29
Harmony Biosciences
HRMY
$1.5B
– –
-376,315
IONS icon
30
Ionis Pharmaceuticals
IONS
$11.7B
– –
-97,300
IOVA icon
31
Iovance Biotherapeutics
IOVA
$840M
– –
-876,009
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$8.18B
– –
-117,500
LEGN icon
33
Legend Biotech
LEGN
$6.07B
– –
-325,953
LLY icon
34
Eli Lilly
LLY
$725B
– –
-17,299
A icon
35
Agilent Technologies
A
$40.5B
– –
-120,485
ACLX icon
36
Arcellx
ACLX
$4.81B
– –
-89,863
AVDL
37
Avadel Pharmaceuticals
AVDL
$1.53B
– –
-385,172
SWTX
38
DELISTED
SpringWorks Therapeutics
SWTX
– –
-378,453
1
2